Skip to content
bio-ARMA Antimicrobials Logo
  • HOME
  • ABOUT
  • SCIENCE
  • PRODUCTS
    • Skin & Wound Care Products
    • Tapes & Adhesives
    • Hand Hygiene
    • Surgical Solutions
    • Casting & Splinting
    • Dental & Orthodontic Products
    • Vascular Access
    • Securement & Immobilization-Dressing Securement
    • Medical Devices & Optical Components
    • Personal Protective Equipment
  • MATERIALS
    • Paper
    • Plastic / Polymers
    • Fabric / Textiles
    • Adhesives
    • Cleaners
  • NEWS
  • CONTACT

Pesticide

Previous Next

Pesticide

March 12th, 2013|Categories: Food & Agricultural, Industrial & Manufacturing|

Share This Story:

FacebookXRedditLinkedInEmail

Related Faqs

Categories

  • Antibiotic resistance
  • Antimicrobial general reference
  • Antiviral
  • bio-ARMA product updates
  • Science and Industry developments

Recent Stories

  • Surfaces near patients with C. auris commonly re-contaminated within hours of cleaning
  • Genomic sequencing reveals MRSA spread within, between ICUs
  • Regions with early interest, adoption of face masks showed modest COVID-19 infection rates
  • The dangerous legacy of COVID-19: A rise in antimicrobial resistance
  • CDC: Medical devices key source of antibiotic-resistant infections
  • Bacteria developing new ways to resist antibiotics, doctors warn
  • Nanofiber-based wound dressings induce production of antimicrobial peptide

About bio-ARMA™

bio-ARMA™ uses a novel bio-based antimicrobial compound to create materials and products highly resistant to the growth of harmful bacteria, viruses and fungus.

In cooperation with selected manufacturing partners, bio-ARMA™ produces high-value medical-grade antimicrobial products for hospitals and the health-care industry, as well as a line of consumer products for home and workplace first aid and care. From bandages and materials, to specialized equipment.

RECENT NEWS & UPDATES

  • Surfaces near patients with C. auris commonly re-contaminated within hours of cleaning
  • Genomic sequencing reveals MRSA spread within, between ICUs
  • Regions with early interest, adoption of face masks showed modest COVID-19 infection rates

CONTACT

Info: info@bio-arma.com

Sales: sales@bio-arma.com

Support: technical@bio-arma.com

© bio-ARMA | All Rights Reserved | info@bio-arma.com | media
XLinkedIn
Page load link
Go to Top